Clinical Trials Browser

OTHER × Non-Muscle Invasive Bladder Neoplasms × erdafitinib × Clear all

NCT04917809 2025-09-10

A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer

Phase 2 Active not recruiting

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms